Summary
CareDx Inc (CareDx) formerly XDx Inc, is a molecular diagnostics company that discovers, develops and commercializes diagnostic surveillance solutions for heart transplant patients. The company markets AlloMap heart transplant molecular test, a gene expression test which helps clinicians to monitor and identify acute cellular rejection in heart transplant recipients. CareDx also develops products for transplant monitoring including AlloSure, a next-generation sequencing test to detect donor-derived cell-free DNA after transplantation. It uses genomics and bioinformatics technology to develop its products. The company distributes its products directly to transplant centers and their physicians, coordinators and nurse practitioners. CareDx is headquartered in Brisbane, California, the US.
CareDx Inc (CDNA) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
CareDx Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
CareDx Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
CareDx Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
CareDx Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
CareDx Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
CareDx Inc, Medical Equipment, Deal Details 11
Venture Financing 11
XDx Secures US$2.2 Million In Venture Financing 11
Private Equity 11
LinkMed Acquires 50% Stake In Olerup International From NorDiag 11
Partnerships 12
Diaxonhit Enters Into Licensing And Distribution Agreement With XDx For AlloMap Molecular Expression Testing 12
CML HealthCare And XDx Enter Into Licensing Agreement For AlloMap Heart Transplant Test 13
CareDx to Partner with Qiagen 14
CareDx Enters into Co-Development Agreement with Horizon Discovery 15
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 16
Equity Offering 17
CareDx Raises USD9 Million in Public Offering of Shares 17
CareDx Plans to Raise up to USD23 Million in Public offering of Shares 18
CareDx to Raise USD22 Million in Private Placement of Units 19
CareDx Raises USD14 Million in Private Placement of Units 20
CareDx to Raise USD8 Million in Private Placement of Units 22
CareDx Prices IPO for USD40 Million 23
Acquisition 24
Allenex To Sell 2.1% Stake In AnaMar To Koncentra For US$0.3 Million 24
SpinMed Completes Acquisition Of 73.4% Stake In OrtoWay From Allenex 25
CareDx Inc - Key Competitors 27
Key Employees 28
Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Mar 15, 2017: CareDx Reports Preliminary Fourth Quarter and FY 2016 Financial Results 30
Nov 09, 2016: CareDx Reports Third Quarter 2016 Financial Results 32
Aug 10, 2016: CareDx Reports Preliminary Second Quarter 2016 Financial Results 33
May 06, 2016: CareDx Reports First Quarter 2016 Financial Results 35
Mar 24, 2016: CareDx Reports Fourth Quarter and Full Year 2015 Financial Results 36
Corporate Communications 37
Jul 15, 2016: CareDx Appoints Douglas Miller to Its Board of Directors 37
Mar 29, 2016: CareDx Announces New Chief Commercial Officer Todd Whitson 38
Mar 24, 2016: CareDx Announces CFO Transition 39
Product News 40
03/08/2016: CareDx Receives Positive Coverage Decision for AlloMap From TRICARE Covering Over 9 Million Lives of U.S. Military Members and Their Families 40
01/12/2016: CareDx and Diaxonhit Announce Completion of Technology Transfer of AlloMap Test in Europe 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
List of Tables
CareDx Inc, Medical Equipment, Key Facts, 2015 1
CareDx Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
CareDx Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
CareDx Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
CareDx Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
CareDx Inc, Deals By Market, 2011 to YTD 2017 9
CareDx Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
XDx Secures US$2.2 Million In Venture Financing 11
LinkMed Acquires 50% Stake In Olerup International From NorDiag 11
Diaxonhit Enters Into Licensing And Distribution Agreement With XDx For AlloMap Molecular Expression Testing 12
CML HealthCare And XDx Enter Into Licensing Agreement For AlloMap Heart Transplant Test 13
CareDx to Partner with Qiagen 14
CareDx Enters into Co-Development Agreement with Horizon Discovery 15
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 16
CareDx Raises USD9 Million in Public Offering of Shares 17
CareDx Plans to Raise up to USD23 Million in Public offering of Shares 18
CareDx to Raise USD22 Million in Private Placement of Units 19
CareDx Raises USD14 Million in Private Placement of Units 20
CareDx to Raise USD8 Million in Private Placement of Units 22
CareDx Prices IPO for USD40 Million 23
Allenex To Sell 2.1% Stake In AnaMar To Koncentra For US$0.3 Million 24
SpinMed Completes Acquisition Of 73.4% Stake In OrtoWay From Allenex 25
CareDx Inc, Key Competitors 27
CareDx Inc, Key Employees 28
CareDx Inc, Subsidiaries 29
List of Figures
CareDx Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
CareDx Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
CareDx Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
CareDx Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
CareDx Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
CareDx Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
CareDx Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
CareDx Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9
